@article{noauthor_final_1989,
	title = {Final Report on the Aspirin Component of the Ongoing Physicians Health Study},
	author = {{Physicians Health Study Research Group}}
	volume = {321},
	issn = {0028-4793},
	url = {http://www.nejm.org/doi/full/10.1056/NEJM198907203210301},
	doi = {10.1056/NEJM198907203210301},
	abstract = {Althoug chewing willow bark, which has aspirin-like properties, was prescribed for pain relief by Hippocrates in the fifth century B.C., the possible role of aspirin in reducing the risk of cardiovascular disease has been recognized only very recently. Such a possibility derives from the capacity of aspirin in low doses to inhibit cyclooxygenase-dependent platelet enzymes virtually completely, resulting in the inhibition of aggregability for the life of the platelet.1 These effects are so profound that higher doses add little benefit but do increase the risk of side effects.2 Although an early caseâ€“control study3 raised the possibility of a large . . .},
	pages = {129--135},
	number = {3},
	journaltitle = {New England Journal of Medicine},
	urldate = {2012-10-29},
	date = {1989}
}

